COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO PD-1
Combination therapies comprising antibody molecules that specifically bind to PD-1 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders.
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
05.06.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Combination therapies comprising antibody molecules that specifically bind to PD-1 are disclosed. The combination therapies can be used to treat or prevent cancerous or infectious conditions and disorders. |
---|---|
Bibliography: | Application Number: EP20240154217 |